News
ASK MAT
BRA
JERSEY
MAT SAYS
JFSC
AML CODES
news image Published on : 09/09/2026

ASK MAT – What does effectiveness scoring mean in my BRA/EWRA?

ASK MAT – What does effectiveness scoring mean in my BRA/EWRA?

  • I am refreshing our Jersey BRA / EWRA, and the model now includes an “effectiveness score”. The JFSC Compliance Monitoring guidance (last revised 4 June 2026) discusses inherent risk, residual risk, and testing whether controls are operating effectively.

  • What does effectiveness scoring actually mean – and what will the JFSC expect to see?

MAT SAYS: Thank you for an excellent question.

Two uncomfortable truths.

  • THE JFSC DOES NOT PRESCRIBE AN “EFFECTIVENESS SCORE”.

    • No 1–5 scale.

    • No approved formula.

    • No official EWRA schema.

  • AND THE HANDBOOK BRA IS NOT AN ALL-RISKS EWRA.

    • The BRA is AML/CTF/CPF.

    • Principle 3 is all risks as a business enterprise.

    • The 2026 CMP guidance EWRA sits over both.

What the JFSC does require, in each assessment, is this chain:

  • Inherent risk →

  • controls assessed for efficacy and adherence →

  • residual risk →

  • risk-based testing →

  • Updated residual versus appetite.

Warning:

  • Score effectiveness once and apply it to both, and you will fail one of them.

  • Do not treat “we have a policy” as “the control is effective”. That is the mistake they keep finding

THE LABELS LADDER – DO NOT CONFLATE THESE

  1. AML/CTF/CPF BRA

    • Hook = Handbook COP1 / the Money Laundering (Jersey) Order

    • Scope = ML/TF/PF “in the round” (structure, customers, countries, products, delivery)

    • Residual = financial crime residual versus FC appetite

    • Score the FC controls (CDD, screening, monitoring, SARs, training)

  2. PRINCIPLE 3 ENTERPRISE RISK ASSESSMENT

    • Hook = sector Codes, Principle 3 (including 3.1.3.1)

    • Scope = all the risks the firm faces, or may face, as a business enterprise

    • Residual = enterprise residual versus enterprise appetite

    • Score ops, conduct, prudential, cyber, sustainability and financial crime

  3. CMP RISK ASSESSMENT / EWRA (2026 guidance type)

    • Hook = guidance, not a new Code

    • Purpose = a firm-wide inherent/residual view used to aim the CMP

    • Paragraph 3.13 = cover operational, regulatory and financial crime

    • Test the highest residual, after effectiveness – not after a policy inventory

Warning: The 2026 note lists EWRA as one type of assessment.

  • The same table still points to that row at AML/CFT/CPF.

  • That is untidy drafting. It does not repeal COP1, it does not turn the BRA into an all-risks EWRA, and it does not let you exclude financial crime from the EWRA because “FC lives in the BRA”.

  • A CDD control scored effective in the BRA does not automatically score effective for a Principle 3 conduct or operational risk.

THE EFFECTIVENESS LADDER – DO NOT SKIP A RUNG

  1. DESIGN / EFFICACY

    • Are the systems and controls capable of producing the intended outcome?

    • Handbook 2.4.1: efficacy = “capacity to have the desired outcome”

  2. OPERATING EFFECTIVENESS / ADHERENCE

    • Are they complied with in practice?

    • COP5 / COP11: assess effectiveness and compliance, and test that controls are followed

    • Article 11(11) MLO: monitor compliance with and test the effectiveness of policies, awareness and training

  3. RESIDUAL

    • What remains after effectiveness, not after a control inventory?

    • Re-score impact and/or likelihood. Compared to the relevant appetite

    • 2022 BRA feedback: map the effect of controls onto inherent risk, or you cannot defend residual

    • Best practice: score whether the control reduces likelihood, impact, or both – and use CMP / audit findings as the evidence

Good practice (2026):

  • RAG or a numerical rating for transparency.

Poor practice (2013 and 2026):

  • Assuming controls exist, the residual is low; “negative assurance” (no breaches effective).

WHAT MUST MOVE THE SCORE

  • CMP results, breaches, incidents, complaints, exam feedback, audit, and trigger events, not just the annual ritual.

  • The question from the 2023–24 financial crime exams still stands:

Do the results from your CMP testing inform the control assessments in your BRA?

  • Ask it again for Principle 3. If the answer is no, residual is fiction.

  • Do not use CMP completion rate as the score. Tests completed ≠ controls effective.

  • Do not import a group template as the Jersey BRA.

  • Do not take high inherent risk to green on an untested key control.

MAT’S BOTTOM LINE

  • Effectiveness scoring is the evidenced judgement that a control can produce the desired outcome and is operating as intended – so residual is honestly within appetite.

  • Do that twice where you must:

    • In the AML/CTF/CPF BRA and

    • In the Principle 3 enterprise view.

  • Use the 2026 EWRA type to aim testing, not as a third competing assessment and not as a synonym for the Handbook BRA.

  • Residual is calculated on performance, not paper.

  • If the score cannot show which obligation set it answers, which parameter it moved (likelihood/impact/both), what test moved it, and what happens if the next test fails, then it is not an effectiveness score. It is a comfort rating.

SOURCES

Mathew Beale – Chartered FCSI Principal & Director – Comsure Compliance Limited, Comsure Technology Limited, Comsure Mauritius mathew@comsuregroup.com www.comsuregroup.com Direct Tel: +44 (0) 1534 626841 Mobile Tel: +44 (0) 7797 747490

ASK MAT | JERSEY | BRA | EWRA | CMP | PRINCIPLE 3 | JFSC | EFFECTIVENESS

ASK MAT BRA JERSEY MAT SAYS JFSC AML CODES

The Team

Meet the team of industry experts behind Comsure

Find out more

Latest News

Keep up to date with the very latest news from Comsure

Find out more

Gallery

View our latest imagery from our news and work

Find out more

News Disclaimer

As well as owning and publishing Comsure's copyrighted works, Comsure wishes to use the copyright-protected works of others. To do so, Comsure is applying for exemptions in the UK copyright law. There are certain very specific situations where Comsure is permitted to do so without seeking permission from the owner. These exemptions are in the copyright sections of the Copyright, Designs and Patents Act 1988 (as amended)[www.gov.UK/government/publications/copyright-acts-and-related-laws]. Many situations allow for Comsure to apply for exemptions. These include 1] Non-commercial research and private study, 2] Criticism, review and reporting of current events, 3] the copying of works in any medium as long as the use is to illustrate a point. 4] no posting is for commercial purposes [payment]. (for a full list of exemptions, please read here www.gov.uk/guidance/exceptions-to-copyright]. Concerning the exceptions, Comsure will acknowledge the work of the source author by providing a link to the source material. Comsure claims no ownership of non-Comsure content. The non-Comsure articles posted on the Comsure website are deemed important, relevant, and newsworthy to a Comsure audience (e.g. regulated financial services and professional firms [DNFSBs]). Comsure does not wish to take any credit for the publication, and the publication can be read in full in its original form if you click the articles link that always accompanies the news item. Also, Comsure does not seek any payment for highlighting these important articles. If you want any article removed, Comsure will automatically do so on a reasonable request if you email info@comsuregroup.com.  

Archived News

To find our older articles, please click here.

View archive